SRRK: Scholar Rock Holding Corporation Stock

by  •  • Comments Off on SRRK: Scholar Rock Holding Corporation Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 1,142.08
Enterprise Value ($M) 956.15
Book Value ($M) 182.77
Book Value / Share 2.29
Price / Book 6.25
NCAV ($M) 162.42
NCAV / Share 2.04
Price / NCAV 7.03

Profitability (mra)
Return on Invested Capital (ROIC) -0.75
Return on Assets (ROA) -0.58
Return on Equity (ROE) -0.80

Liquidity (mrq)
Quick Ratio 6.58
Current Ratio 6.58

Balance Sheet (mrq) ($M)
Current Assets 246.93
Assets 267.29
Liabilities 84.51
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -171.29
Net Income -165.79
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -145.23
Cash from Investing 41.14
Cash from Financing 102.57

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G Orbimed Advisors Llc 4.10
02-14 13G/A Price T Rowe Associates Inc /md/ 12.30 16.83
02-14 13G/A ARCH Venture Fund VIII, L.P.
02-14 13G/A Redmile Group, LLC 9.90 40.09
02-09 13G/A Fmr Llc 15.00 39.21
02-09 13G/A Polaris Venture Partners VI, L.P. 3.70 -35.41
02-09 13G/A Artal International S.C.A. 17.40 21.59
01-26 13G BlackRock Inc. 6.90 355.38
10-18 13D/A Samsara BioCapital, L.P. 11.00 38.80

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-03-19 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-17 469,394 649,988 72.22
2024-05-16 208,799 257,745 81.01
2024-05-15 93,403 969,841 9.63
2024-05-14 71,134 461,506 15.41
2024-05-13 79,230 720,010 11.00

(click for more detail)

Similar Companies
SPRB – Spruce Biosciences, Inc. SPRO – Spero Therapeutics, Inc.
SRPT – Sarepta Therapeutics, Inc. STOK – Stoke Therapeutics, Inc.
STTK – Shattuck Labs, Inc.


Financial data and stock pages provided by
Fintel.io